Literature DB >> 28554546

Cyclodextrin-based metal-organic frameworks particles as efficient carriers for lansoprazole: Study of morphology and chemical composition of individual particles.

Xue Li1, Tao Guo2, Laurent Lachmanski3, Francesco Manoli4, Mario Menendez-Miranda5, Ilse Manet4, Zhen Guo2, Li Wu2, Jiwen Zhang6, Ruxandra Gref7.   

Abstract

Cyclodextrin-based metal-organic frameworks (CD-MOFs) represent an environment-friendly and biocompatible class of MOFs drawing increasing attention in drug delivery. Lansoprazole (LPZ) is a proton-pump inhibitor used to reduce the production of acid in the stomach and recently identified as an antitubercular prodrug. Herein, LPZ loaded CD-MOFs were successfully synthesized upon the assembly with γ-CD in the presence of K+ ions using an optimized co-crystallization method. They were characterized in terms of morphology, size and crystallinity, showing almost perfect cubic morphologies with monodispersed size distributions. The crystalline particles, loaded or not with LPZ, have mean diameters of around 6μm. The payloads reached 23.2±2.1% (wt) which corresponds to a molar ratio of 1:1 between LPZ and γ-CD. It was demonstrated that even after two years storage, the incorporated drug inside the CD-MOFs maintained its spectroscopic characteristics. Molecular modelling provided a deeper insight into the interaction between the LPZ and CD-MOFs. Raman spectra of individual particles were recorded, confirming the formation of inclusion complexes within the tridimensional CD-MOF structures. Of note, it was found that each individual particle had the same chemical composition. The LPZ-loaded particles had remarkable homogeneity in terms of both drug loading and size. These results pave the way towards the use of CD-MOFs for drug delivery purposes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD-MOF; Individual particle characterization; Metal-organic frameworks; Nanoparticle; Raman spectroscopy; γ-cyclodextrin

Mesh:

Substances:

Year:  2017        PMID: 28554546     DOI: 10.1016/j.ijpharm.2017.05.056

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  MOF Capacitates Cyclodextrin to Mega-Load Mode for High-Efficient Delivery of Valsartan.

Authors:  Wei Zhang; Tao Guo; Caifen Wang; Yuanzhi He; Xi Zhang; Guangyu Li; Yizhi Chen; Jun Li; Yangjing Lin; Xu Xu; Li Wu; Suxia Zhang; Jiwen Zhang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

2.  Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery.

Authors:  Kena Zhao; Tao Guo; Caifen Wang; Yong Zhou; Ting Xiong; Li Wu; Xue Li; Priyanka Mittal; Senlin Shi; Ruxandra Gref; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-05-07       Impact factor: 11.413

3.  Preparation and Characterization of a Hybrid Complex of Cyclodextrin-Based Metal-Organic Frameworks-1 and Ascorbic Acid Derivatives.

Authors:  Ayumi Nanri; Masaaki Yoshida; Yoshiyuki Ishida; Daisuke Nakata; Keiji Terao; Florencio Jr Arce; Gerard Lee See; Takashi Tanikawa; Yutaka Inoue
Journal:  Materials (Basel)       Date:  2021-11-29       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.